Compare ALEMBIC LTD with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs PANACEA BIOTECH - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD PANACEA BIOTECH ALEMBIC LTD/
PANACEA BIOTECH
 
P/E (TTM) x 70.4 10.4 674.0% View Chart
P/BV x 2.9 2.2 130.0% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
PANACEA BIOTECH
Mar-19
ALEMBIC LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs72354 20.4%   
Low Rs34138 24.5%   
Sales per share (Unadj.) Rs4.774.6 6.3%  
Earnings per share (Unadj.) Rs6.16.7 91.4%  
Cash flow per share (Unadj.) Rs6.215.5 40.3%  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.757.2 71.1%  
Shares outstanding (eoy) m267.0361.25 436.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.3 341.6%   
Avg P/E ratio x8.736.8 23.6%  
P/CF ratio (eoy) x8.515.9 53.4%  
Price / Book Value ratio x1.34.3 30.3%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,13915,061 93.9%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m2071,471 14.1%   
Avg. sales/employee Rs ThNM1,973.6-  
Avg. wages/employee Rs ThNM635.6-  
Avg. net profit/employee Rs ThNM176.8-  
INCOME DATA
Net Sales Rs m1,2554,567 27.5%  
Other income Rs m37045 826.3%   
Total revenues Rs m1,6254,612 35.2%   
Gross profit Rs m1112,030 5.5%  
Depreciation Rs m38540 7.0%   
Interest Rs m21,048 0.2%   
Profit before tax Rs m442486 90.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2477 31.1%   
Profit after tax Rs m1,630409 398.4%  
Gross profit margin %8.944.4 19.9%  
Effective tax rate %5.415.9 34.2%   
Net profit margin %129.89.0 1,449.6%  
BALANCE SHEET DATA
Current assets Rs m1,8672,415 77.3%   
Current liabilities Rs m5919,077 6.5%   
Net working cap to sales %101.6-145.9 -69.7%  
Current ratio x3.20.3 1,187.3%  
Inventory Days Days9465 144.8%  
Debtors Days Days7471 103.7%  
Net fixed assets Rs m1,7918,333 21.5%   
Share capital Rs m53461 871.3%   
"Free" reserves Rs m10,3243,443 299.9%   
Net worth Rs m10,8583,504 309.9%   
Long term debt Rs m41461 8.9%   
Total assets Rs m11,59113,755 84.3%  
Interest coverage x260.91.5 17,822.3%   
Debt to equity ratio x00.1 2.9%  
Sales to assets ratio x0.10.3 32.6%   
Return on assets %14.110.6 132.9%  
Return on equity %15.011.7 128.6%  
Return on capital %15.238.7 39.3%  
Exports to sales %1.520.9 7.4%   
Imports to sales %21.08.1 257.6%   
Exports (fob) Rs m19954 2.0%   
Imports (cif) Rs m263372 70.8%   
Fx inflow Rs m191,203 1.6%   
Fx outflow Rs m264467 56.5%   
Net fx Rs m-244736 -33.2%   
CASH FLOW
From Operations Rs m2361,049 22.5%  
From Investments Rs m-224-54 418.7%  
From Financial Activity Rs m-27-1,011 2.6%  
Net Cashflow Rs m-15-20 75.1%  

Share Holding

Indian Promoters % 64.0 74.5 85.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.6 33.3%  
FIIs % 9.7 1.3 746.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 23.6 110.6%  
Shareholders   54,701 10,259 533.2%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   DR. DATSONS LABS  BIOCON   FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 205 Points Lower; Power and Realty Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 21, 2020 03:35 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS